There is a question an experienced leader asks before committing the next ten years of their life to a company. It is not “How much can I earn?” but something else: can I verify everything I am being told here? Every layer. Every number. Every fact.
That question is the starting point for our new video investigation. I took a working checklist used by top leaders—a set of 23 criteria for choosing a company—and applied it to JIMON GROUP point by point. Government registries, patent databases, government orders and the official marketing plan: everything is open, shown on screen and available for independent verification.
No advertising. Just analysis, as it might be conducted in a scientific laboratory or during a confidential due-diligence review.
What you will learn from this video
The video is structured as an investigation that moves from simple questions to more complex ones. First, the company’s foundations. Then, the things usually left out of presentations.
Legality and history. You will see JIMON GROUP’s regulatory record in China’s public government registers, including Ministry of Commerce entries and a registration history spanning more than thirty years. You will also see why, for a professional, a company that has navigated three decades of crises and legislative change is no longer a matter of luck, but proof of the system’s ability to adapt.
The product test—the most unforgiving one. Remove everything related to the partner model: bonuses, ranks and the marketing plan. Would people still buy the products simply because they need them? The video examines why JIMON’s answer to that question is framed around six product categories, three hundred registration documents and decades of sales that predated the current partner programme.
A tradition that cannot simply be copied. Hundreds of companies use the phrase “thousand-year-old Chinese medicine.” But you will learn why JIMON’s relocation of its headquarters to Anguo in 2016 matters: the city is officially described as a pharmaceutical capital with around two and a half millennia of continuous herbal trade, and this changes the very basis of trust in the product.
Science and patents. Not stock photos of people in white coats, but long-term partnerships with six research organisations, including the state-affiliated China Academy of Chinese Medical Sciences and a specialist university in Tianjin. The video also examines a specific patent, CN109601880B, from the official register of China’s National Intellectual Property Administration, including its number, date and stated invention.
Manufacturing and independent recognition. More than 660 hectares of fields growing medicinal crops, full-cycle factories, and an industrial park with investments exceeding ten billion yuan—all alongside observation corridors through which a visitor can follow the route from raw material to packaging. There is also the December verdict of the Hebei provincial government: JIMON GROUP was named among the region’s ten Quality Award recipients, in a province whose population exceeds that of most European countries. This is a signal no copywriter can manufacture.
The second half of the investigation: the marketing plan under scrutiny
After reviewing the company, the video turns to a different subject: the mechanism by which economic value is distributed within the partner structure, subjected to the same rigorous analysis.
Here, viewers will see what a newcomer to a marketing plan simply fails to notice: why a tiered referral bonus of up to 60%, with payments extending five generations deep, is designed for structure-builders rather than isolated individuals; why the rule that “up to 70% of volume may come from one branch” is presented as an incentive for effective growth instead of a penalty for a leader with a strong team; how differential-volume bonuses work, forming the mechanism behind the substantial passive incomes of top leaders; and why the system’s highest ranks measure a leader not by the number of people they personally invited, but by the number of capable leaders they developed within the structure.
Particular attention is given to six things simply absent from this structure: volume resets, rank re-certification, mandatory personal volume, participation fees, rigid deadlines and forced upgrades. Anyone who has ever lost a bonus because they were forty dollars short on the last day of the month will understand the significance of this list without further explanation.
The point is not the amount, but the synergy
Two or three strong criteria make a good company. Eight to ten make a very strong player. But the most interesting part of this investigation is what happens when all twenty-three criteria are satisfied and connected as one system: the product supports the marketing, the marketing supports research, and research supports the product. It is a positive feedback loop that reinforces itself.
This is where real investigations can deliver their most valuable turn. The opening question—“Is JIMON GROUP worth investing my time and reputation in?”—is turned around by the end of the video. You will hear the revised question in the final minutes. I will not spoil it; the turn is worth watching for yourself.
The honest boundary of the investigation
I do not treat anything as proven unless it is supported by evidence. For example, the company’s reported turnover in each country within its international network—Singapore, Malaysia, South Korea, Japan, Australia, Canada, Indonesia, Slovakia and Kazakhstan—has not yet been verified through publicly available independent sources. The video states this directly as a limitation, rather than hiding it behind attractive wording. That distinction is what separates an investigation from a presentation.
If, after watching, you find even one fact that raises a doubt, write to me. I am prepared to return to any of the twenty-three points, open the sources and check everything again. A genuine investigation is not afraid of being checked.
And if your doubts have been resolved, every professional will draw their own conclusion.
The investigation continues.
Research keys
Browse the topic archives for this article.